Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Berry

Showing results (601-610 of 698) with videos related to

Pageof 70
Sort By:
European Heart Journal|August 30, 2020
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Nadia Bouabdallaoui, Jean-Claude Tardif, David D Waters, et al.
Journal of the American College of Cardiology|October 19, 2019
Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary SyndromeKuan Ken Lee, Amy V Ferry, Atul Anand, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 11, 2025
Association between pathophysiological coronary artery disease patterns and perivascular adipose tissue densityChieh Yang Koo, Carlos Collet, Kazumasa Ikeda, et al.
JACC. Cardiovascular Interventions|August 29, 2021
Safety of Selective Intracoronary Hypothermia During Primary Percutaneous Coronary Intervention in Patients With Anterior STEMIMohamed El Farissi, Richard Good, Thomas Engstrøm, et al.
Circulation. Cardiovascular Interventions|May 1, 2025
Novel Contrast-Derived Indices of Coronary Microvascular Function: Potential Clinical and Cost BenefitsDaniel T Y Ang, Damien Collison, Ross J McGeoch, et al.
Open Heart|April 17, 2026
Non-invasive endotyping improves treatment satisfaction and prescribing appropriateness in patients with angina and no obstructive coronary artery diseaseConor P Bradley, Gemma McKinley, Vanessa Orchard, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 15, 2020
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Michelle Samuel, Jean-Claude Tardif, Paul Khairy, et al.
European Heart Journal. Acute Cardiovascular Care|September 23, 2023
2023 ESC Guidelines for the management of acute coronary syndromesRobert A Byrne, Xavier Rossello, J J Coughlan, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2025
Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trialMatthew Tate, Christopher J R Illingworth, Gordon MacGregor, et al.
Giornale Italiano Di Cardiologia (2006)|January 31, 2024
[2023 ESC Guidelines for the management of acute coronary syndromes]Robert A Byrne, Xavier Rossello, J J Coughlan, et al.
Pageof 70

Showing results (601-610 of 698) with videos related to

Sort By:
Pageof 70
European Heart Journal|August 30, 2020
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Nadia Bouabdallaoui, Jean-Claude Tardif, David D Waters, et al.
Journal of the American College of Cardiology|October 19, 2019
Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary SyndromeKuan Ken Lee, Amy V Ferry, Atul Anand, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 11, 2025
Association between pathophysiological coronary artery disease patterns and perivascular adipose tissue densityChieh Yang Koo, Carlos Collet, Kazumasa Ikeda, et al.
JACC. Cardiovascular Interventions|August 29, 2021
Safety of Selective Intracoronary Hypothermia During Primary Percutaneous Coronary Intervention in Patients With Anterior STEMIMohamed El Farissi, Richard Good, Thomas Engstrøm, et al.
Circulation. Cardiovascular Interventions|May 1, 2025
Novel Contrast-Derived Indices of Coronary Microvascular Function: Potential Clinical and Cost BenefitsDaniel T Y Ang, Damien Collison, Ross J McGeoch, et al.
Open Heart|April 17, 2026
Non-invasive endotyping improves treatment satisfaction and prescribing appropriateness in patients with angina and no obstructive coronary artery diseaseConor P Bradley, Gemma McKinley, Vanessa Orchard, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 15, 2020
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Michelle Samuel, Jean-Claude Tardif, Paul Khairy, et al.
European Heart Journal. Acute Cardiovascular Care|September 23, 2023
2023 ESC Guidelines for the management of acute coronary syndromesRobert A Byrne, Xavier Rossello, J J Coughlan, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2025
Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trialMatthew Tate, Christopher J R Illingworth, Gordon MacGregor, et al.
Giornale Italiano Di Cardiologia (2006)|January 31, 2024
[2023 ESC Guidelines for the management of acute coronary syndromes]Robert A Byrne, Xavier Rossello, J J Coughlan, et al.
Pageof 70